KYDVRIXO
Live / Registered — Registered (as of 17 Dec 2024)
What this means for you
Registered since 17 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98294704
- Registration number
- 7606337
- Mark type
- Stylized text
- Filed
- 01 Dec 2023
- Published for opposition
- 15 Oct 2024
- Registered
- 17 Dec 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 17 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2024 — PUBLISHED FOR OPPOSITION
- 25 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Sept 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 05 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Jun 2024 — NON-FINAL ACTION E-MAILED
- 25 Jun 2024 — NON-FINAL ACTION WRITTEN
- 21 Jun 2024 — ASSIGNED TO EXAMINER
- 25 Feb 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED